Most Rett Syndrome Trial Participants Continued Trofinetide After Commercial Approval
A retrospective study linking clinical trial records with specialty pharmacy dispensing found that over seventy-eight percent of eligible Rett syndrome ...
A retrospective study linking clinical trial records with specialty pharmacy dispensing found that over seventy-eight percent of eligible Rett syndrome ...
In the randomized phase II AdvanTIG-203 trial, adding the anti-TIGIT antibody ociperlimab to tislelizumab did not significantly improve response rates ...
A Bayesian network meta-analysis of seven randomized trials indicates that garadacimab achieved the highest probability of preventing attacks among pharmacological ...
A prospective phase IV study across nine Indian hospitals found that a fixed-dose combination of prolonged-release pregabalin and etoricoxib significantly ...
Detailed safety results from the phase 3 NATALEE trial demonstrate that adding ribociclib to nonsteroidal aromatase inhibitors maintained manageable adverse ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.